Zacks Investment Research Downgrades Israel Chemicals Shs (ICL) to Sell, Report finds

Zacks Investment Research Downgrades Israel Chemicals Shs (ICL) to Sell, Report finds

Israel Chemicals Shs (NYSE:ICL) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a note issued to investors on Wednesday.

According to Zacks, “Israel Chemicals Ltd. is a manufacturer of specialty fertilizers and specialty phosphates, flame retardants and water treatment solutions. It operates primarily in three markets: agriculture, food and engineered materials. The Company’s products include bromine specialty chemicals, potash, phosphate fertilizers, and specialty performance and industrial products. It markets its products primarily in Israel, Europe, and the Americas. Israel Chemicals Ltd. is headquartered in Tel Aviv, Israel. “

Israel Chemicals Shs (NYSE:ICL) traded down 1.09% during midday trading on Wednesday, hitting $4.55. 403,465 shares of the stock traded hands. The stock’s 50-day moving average price is $4.42 and its 200 day moving average price is $4.06. Israel Chemicals Shs has a 52 week low of $3.52 and a 52 week high of $5.02. The company’s market capitalization is $5.80 billion.

Israel Chemicals Shs (NYSE:ICL) last issued its quarterly earnings data on Wednesday, November 23rd. The company reported $0.09 EPS for the quarter, meeting the consensus estimate of $0.09. The company earned $1.38 billion during the quarter. Israel Chemicals Shs had a negative net margin of 1.06% and a positive return on equity of 16.76%. Israel Chemicals Shs’s revenue was up .3% on a year-over-year basis. During the same period in the prior year, the firm posted $0.12 EPS. On average, equities research analysts predict that Israel Chemicals Shs will post $0.33 EPS for the current year.

Large investors have recently made changes to their positions in the stock. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Israel Chemicals Shs by 32.8% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 99,216 shares of the company’s stock valued at $386,000 after buying an additional 24,505 shares during the last quarter. Migdal Insurance & Financial Holdings Ltd. bought a new stake in shares of Israel Chemicals Shs during the second quarter valued at about $11,135,000. Scopus Asset Management L.P. bought a new stake in shares of Israel Chemicals Shs during the third quarter valued at about $1,949,000. Jarislowsky Fraser Ltd raised its stake in shares of Israel Chemicals Shs by 3.1% in the second quarter. Jarislowsky Fraser Ltd now owns 29,084 shares of the company’s stock valued at $113,000 after buying an additional 887 shares during the last quarter. Finally, Foyston Gordon & Payne Inc raised its stake in shares of Israel Chemicals Shs by 0.8% in the second quarter. Foyston Gordon & Payne Inc now owns 2,008,715 shares of the company’s stock valued at $7,834,000 after buying an additional 16,631 shares during the last quarter. Institutional investors and hedge funds own 6.29% of the company’s stock.

Get a free copy of the Zacks research report on Israel Chemicals Shs (ICL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Related posts

Leave a Comment

Zacks Investment Research Downgrades Israel Chemicals Shs (ICL) to Sell

Zacks Investment Research Downgrades Israel Chemicals Shs (ICL) to Sell

Israel Chemicals Shs (NYSE:ICL) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a note issued to investors on Wednesday.

According to Zacks, “Israel Chemicals Ltd. is a manufacturer of specialty fertilizers and specialty phosphates, flame retardants and water treatment solutions. It operates primarily in three markets: agriculture, food and engineered materials. The Company’s products include bromine specialty chemicals, potash, phosphate fertilizers, and specialty performance and industrial products. It markets its products primarily in Israel, Europe, and the Americas. Israel Chemicals Ltd. is headquartered in Tel Aviv, Israel. “

Israel Chemicals Shs (NYSE:ICL) traded down 1.09% during midday trading on Wednesday, hitting $4.55. 403,465 shares of the stock traded hands. The stock’s 50-day moving average price is $4.42 and its 200 day moving average price is $4.06. Israel Chemicals Shs has a 52 week low of $3.52 and a 52 week high of $5.02. The company’s market capitalization is $5.80 billion.

Israel Chemicals Shs (NYSE:ICL) last issued its quarterly earnings data on Wednesday, November 23rd. The company reported $0.09 EPS for the quarter, meeting the consensus estimate of $0.09. The company earned $1.38 billion during the quarter. Israel Chemicals Shs had a negative net margin of 1.06% and a positive return on equity of 16.76%. Israel Chemicals Shs’s revenue was up .3% on a year-over-year basis. During the same period in the prior year, the firm posted $0.12 EPS. On average, equities research analysts predict that Israel Chemicals Shs will post $0.33 EPS for the current year.

Large investors have recently made changes to their positions in the stock. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Israel Chemicals Shs by 32.8% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 99,216 shares of the company’s stock valued at $386,000 after buying an additional 24,505 shares during the last quarter. Migdal Insurance & Financial Holdings Ltd. bought a new stake in shares of Israel Chemicals Shs during the second quarter valued at about $11,135,000. Scopus Asset Management L.P. bought a new stake in shares of Israel Chemicals Shs during the third quarter valued at about $1,949,000. Jarislowsky Fraser Ltd raised its stake in shares of Israel Chemicals Shs by 3.1% in the second quarter. Jarislowsky Fraser Ltd now owns 29,084 shares of the company’s stock valued at $113,000 after buying an additional 887 shares during the last quarter. Finally, Foyston Gordon & Payne Inc raised its stake in shares of Israel Chemicals Shs by 0.8% in the second quarter. Foyston Gordon & Payne Inc now owns 2,008,715 shares of the company’s stock valued at $7,834,000 after buying an additional 16,631 shares during the last quarter. Institutional investors and hedge funds own 6.29% of the company’s stock.

Get a free copy of the Zacks research report on Israel Chemicals Shs (ICL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Related posts

Leave a Comment